Key Updates in Bipolar Depression

1.00 CME
1.00 CNE
60 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patient Photo

Overview

Provider Statement

This continuing education activity is provided by Vindico Medical Education

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.


Support Statement

This activity is supported by educational grants from Intra-Cellular Therapies, Inc. and Sunovion Pharmaceuticals Inc.


Activity Description

Bipolar disorder is a serious but often underdiagnosed condition. In the United States, the estimated 12-month and lifetime prevalence is 2.6% to 2.8% and 4.4%, respectively, with 82.9% of patients reporting serious impairment. Bipolar disorder is associated with a 10- to 20-year loss of lifespan, and 6% to 7% of patients die by suicide. Despite the serious effects of untreated bipolar disorder and its associated comorbidities, as many as 33% of patients experience a 10-year gap between exhibiting symptoms and obtaining a diagnosis to receive appropriate treatment. Newer and emerging therapies may offer additional value to patients compared with traditionally used therapies. In this podcast series, expert clinicians discuss the mechanisms of action of currently available and emerging drugs, the clinical data of therapies for treating bipolar depression, and how the COVID-19 pandemic has influenced the management of patients with bipolar depression.


Target Audience

The intended audience for this activity is psychiatrists, psychiatry nurses, psychiatry nurse practitioners, and other health care professionals involved in the management of patients with bipolar disorder.


Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Compare the mechanisms of action of currently available and emerging treatments for bipolar depression.
  • Examine the efficacy of currently available and emerging therapies in patients with bipolar depression to better understand how these agents can be used to individualize treatment.
  • Assess and address patient concerns about adverse effects of bipolar depression treatments to reduce barriers, personalize medication selection, and improve treatment adherence.
  • Explain how the COVID-19 pandemic has affected the mental health and well-being of patients with bipolar depression, including their access to treatment.

Activity Chair

Leslie Citrome, MD, MPH
Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, NY

Faculty

Joseph F. Goldberg, MD
Clinical Professor of Psychiatry
The Icahn School of Medicine at Mount Sinai
Director, Affective Disorders Research Program
Silver Hill Hospital
New York, NY

Manpreet K. Singh, MD, MS
Associate Professor of Psychiatry and Behavioral Sciences
Stanford University
Stanford, CA


Planners/Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Barbara A. Niedz, PhD, RN, CPHQ


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vindico Medical Education, LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Vindico Medical Education will provide a maximum of 1.0 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, December 31, 2021, to December 30, 2022.


How to Participate in This Activity and Obtain CE Credit

To participate in this CE activity, you must read the objectives, answer the polling and pretest questions, listen to the podcasts, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ or Contact Hours Certificate.


Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Activity chair and faculty report the following relevant financial relationship(s)

Leslie Citrome, MD, MPH
Consultant: AbbVie/Allergan, Alkermes, Angelini, Astellas, Avanir, Intra-Cellular Therapies, Janssen, Lundbeck, Otsuka, Sunovion
Speaker Contracted by Ineligible Company: AbbVie/Allergan, Alkermes, Intra-Cellular Therapies, Janssen, Lundbeck, Otsuka, Sunovion

Joseph F. Goldberg, MD
Consultant: Lundbeck, Sunovion
Speaker Contracted by Ineligible Company: AbbVie, Alkermes, Intracellular Therapies, Sunovion

Manpreet K. Singh, MD, MS
Advisor: Sunovion
Consultant: Johnson & Johnson

Reviewers/Planners report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


ADA Compliance

In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this Podcast series is available upon request. Requests should include the Podcast title and can be emailed to cme@vindicoCME.com. Requests will be honored within 3-5 business days.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com